SAT-673 Acute Onset Type 1 Diabetes Mellitus Caused by the Checkpoint Inhibitor Nivolumab

Background. Checkpoint inhibitors are monoclonal antibodies that augment immune system antitumor activity. Nivolumab is a checkpoint inhibitor that targets the programmed cell death receptor 1 (PD-1). Approximately 15% of patients treated with checkpoint inhibitors experience endocrine immune-relate...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Endocr Soc
Asıl Yazarlar: Ansari, Mohammad Jamal Uddin, Ahmed, Mahreen, Parveen, Sanober, Mariam, Murtaza Ali, Jabri, Hadoun, Rehman, Anis, Jakoby, Michael G
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Diabetes Mellitus and Glucose Metabolism
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208335/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.325
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller